课题基金 / 基金详情

STAVUDINE INTERACTION WITH AGENTS FOR OPPORTUNISTIC INFECTIONS IN HIV PATIENTS

STAVUDINE INTERACTION WITH AGENTS FOR OPPORTUNISTIC INFECTIONS IN HIV PATIENTS
司他夫定与 HIV 患者机会性感染药物的相互作用
批准号:
6161414
负责人:
S PISCITELLI
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

S PISCITELLI的其他基金

相似基金

相关文献

中文摘要
翻译
这项在HIV感染患者中进行的药物相互作用研究旨在 表征司他夫定(D4 T)单独给药时的药代动力学, 与三种常用于治疗机会性 感染. 10名患者(1名女性,9名男性)入组研究:8名白人, 1名西班牙裔和1名非洲裔美国人。入组时的平均CD 4计数为 62个细胞/mm 3(范围9-143)。 有2例III级毒性:2例患者发生中性粒细胞减少症,推测为 由于其(甲氧苄啶/磺胺甲恶唑)预防。这些剧集 通过将患者转换为喷他脒雾化吸入而解决。 按研究药物列出的不良反应包括(1)D4 T,1例患者 报告周围神经病变;(2)克拉霉素组,4例患者 报告“味道不好”,3人报告胃肠道症状,我报告 皮疹;(3)利福布雷定,1例患者报告皮疹;(4)氟康唑 和更昔洛韦,各有3例患者报告胃肠道症状。 截至1997年1月,只分析了D4 T水平。组合 氟康唑、利福布汀、克拉霉素和更昔洛韦 显著改变D4 T峰值水平、D4 T曲线下面积或时间 达到最高D4 T水平这些发现表明,这些药物可以 安全地与D4 T联合使用。 合并药物水平的药代动力学研究正在进行中;最终 预计在未来三至四个月内会有结果。
英文摘要
This drug interaction study in HIV-infected patients sought to characterize the pharmacokinetics of stavudine (D4T) when given alone and in combination with three drugs commonly used to manage opportunistic infections. Ten patients (1 female, 9 males) were enrolled in the study: 8 Caucasians, 1 Hispanic, and 1 African-American. The mean CD4 count at enrollment was 62 cells/mm3 (range 9-143). There were 2 Grade III toxicities: 2 patients had neutropenia, presumably due to their (trimethoprim/sulfamethoxazole) prophylaxis. These episodes were resolved by switching the patients to aerosolized pentamidine. Adverse effects by study medication included (1) for D4T, 1 patient reported peripheral neuropathy; (2) for clarithromycin, 4 patients reported "bad taste," 3 reported gastrointestinal symptoms, and I reported rash; (3) for rifabutin, 1 patient reported rash; and (4) for fluconazole and ganciclovir, 3 patients each reported gastrointestinal symptoms. As of January 1997, only the D4T levels have been analyzed. Combinations of fluconazole, rifabutine, clarithromycin, and ganciclovir did not significantly alter the peak D4T level, D4T area under the curve, or time to maximum D4T level. These findings suggest that these drugs can be safely used in combination with D4T. Pharmacokinetic studies of the concomitant drug levels are ongoing; final results are expected in the next 3-4 months.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF STAVUDINE WITH AGENTS FOR OPPORTUNISTIC INFECTIONS IN HIV PATIENTS
  • 批准号:
    2456657
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    S PISCITELLI
  • 依托单位:
EFFECT OF RITONAVIR ON THE PHARMACOKINETICS OF MEPERIDINE IN HIV NEGATIVE SUBJECT
  • 批准号:
    6163407
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    S PISCITELLI
  • 依托单位:
海外基金